Loading...
Loading...
Browse all stories on DeepNewz
VisitWill Radionetics receive FDA approval for a new radiopharmaceutical by mid-2025?
Yes • 50%
No • 50%
FDA approval announcements
Radionetics Oncology Enters $140M Strategic Agreement With Lilly, Acquisition Option for $1B
Jul 1, 2024, 02:51 PM
Radionetics Oncology has entered into a strategic agreement with Eli Lilly and Company. As part of the deal, Radionetics will receive a $140 million upfront payment. In return, Lilly gains the exclusive right to acquire Radionetics for $1 billion. The agreement focuses on enhancing Lilly's cancer drug pipeline with radiopharmaceuticals developed by Radionetics. Lilly inks the deal with the biotech startup to expand its radiopharmaceutical offerings.
View original story
Yes • 50%
No • 50%
Accelerated Approval • 25%
Full Approval • 25%
Conditional Approval • 25%
No Approval • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Less than $140 million • 33%
$140 million - $500 million • 33%
More than $500 million • 33%
FDA approval • 25%
Acquisition by Lilly • 25%
Partnership with another pharma company • 25%
New clinical trial initiation • 25%